Abstract

ARTIFICIAL INTELLIGENCE: PAST, PRESENT AND FUTURE

Pooja Agrawal, Virendra Kushwaha* and Nasreen Fatma Khan

ABSTRACT

As every aspect of life is constantly subject to change, therefore one of the main aims of humans is to control these changes for our benefit. This is especially true in the field of medicine and pharmaceuticals where the reason for advancement has been an enhancement in the methods of developing and testing new drugs. This motivates the use of artificial intelligence (AI) because it can handle large volumes of data with enhanced automation. Artificial intelligence (AI) refers to a computer's or a robot's ability to do tasks that would typically need human intelligence and judgment. It’s a technology-based system involving various advanced tools and networks that can mimic human intelligence. The current degree of advancement in medical plans and assembling of these items can’t address the issues of customized medication. Based on new analytic instruments and recent improvements in genomics and diagnostics have enabled new and creative pharmaceutical products and approaches. Medicines that are tailored to the patient’s biology would improve the efficiency of this industry. E-VAI is an analytical and decision-making AI platform, which uses Machine Learning algorithms along with an easy-to-use user interface to create analytical roadmaps based on competitors, key stakeholders, and currently held market share to predict key drivers in sales of pharmaceuticals, thus helping marketing executives to allocate resources for maximum market share gain, reversing poor sales and enabled them to anticipate where to make investments. AI approaches, coupled with big data, are expected to substantially improve the effectiveness of drug repurposing and will make it become an invaluable tool in the pharmaceutical industry as well.

Keywords: Drugs, Artificial intelligence, Human intelligence, Pharmaceutical.